In summary, our findings show that Smad8 is increased in DMD muscle and may promote dystrophic signaling through its suppression of key myomiRs, inhibition of myoblast differentiation, and attenuation of disease-mitigating gene programs. This evidence concerns the gene SMAD9 and Duchenne muscular dystrophy.